Physician profile
Norman E Risinger
NPI 1063406692
$20,789.68
in general payments reported to CMS, 2019-2025
49 companies · $2,187 in 2025
The $2,187 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $1,354 · 2021: $1,081 · 2022: $1,748 · 2023: $2,012 · 2024: $1,598 · 2025: $2,187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,777 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,776.55 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $5,623.56 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $3,756.34 | 2019-2025 | Evkeeza |
| Amgen INC. | $1,337.56 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $956.46 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $918.26 | 2019-2024 | Xarelto |
| Pfizer INC. | $741.16 | 2019-2025 | |
| Boston Scientific Corporation | $589.21 | 2019-2025 | Watchman Flx, Bodyguardian |
| Astrazeneca Pharmaceuticals LP | $580.37 | 2019-2025 | Farxiga, Brilinta, Lokelma |
| Esperion Therapeutics, INC. | $557.31 | 2020-2025 | Nexletol |
| Kowa Pharmaceuticals America, INC. | $530.82 | 2019-2024 | Livalo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $509.38 | 2019-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $471.57 | 2019-2025 | Camzyos, Eliquis |
| Medtronic, INC. | $455.64 | 2024-2025 | Corevalve Evolut R |
| Amarin Pharma, INC. | $444.10 | 2019-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $285.53 | 2019-2023 | Lifevest |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $271.38 | 2019-2024 | Amplatzer Amulet |
| Impulse Dynamics (USA) INC. | $267.22 | 2022-2023 | Optimizer |
| Merck Sharp & Dohme LLC | $228.68 | 2022-2025 | Verquvo, Capvaxive |
| Medicure Pharma INC. | $199.64 | 2020-2023 | Zypitamag |
| Alnylam Pharmaceuticals INC. | $187.92 | 2023-2025 | Onpattro, Amvuttra |
| Vital Connect, INC | $182.73 | 2023-2025 | Vitalpatch Rtm |
| Jazz Pharmaceuticals INC. | $166.65 | 2021-2024 | |
| Arbor Pharmaceuticals, INC. | $157.79 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $153.50 | 2025 | |
| Avadel Cns Pharmaceuticals, LLC | $129.86 | 2023-2025 | Lumryz |
| Kiniksa Pharmaceuticals International, Plc | $109.47 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $104.93 | 2024-2025 | |
| Abiomed | $98.95 | 2024-2025 | Impella |
| Baxter Healthcare | $83.33 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Edwards Lifesciences Corporation | $80.57 | 2019-2021 | |
| Kiniksa Pharmaceuticals, LTD. | $65.07 | 2021-2023 | Arcalyst |
| Axsome Therapeutics, INC. | $56.51 | 2025 | Sunosi |
| Novo Nordisk INC | $53.13 | 2022 | |
| Preventice Services, LLC | $45.44 | 2020-2021 | |
| Lexicon Pharmaceuticals, INC. | $42.08 | 2024 | |
| Cvrx, INC. | $40.64 | 2023 | Barostim Neo System |
| Azurity Pharmaceuticals, INC. | $36.26 | 2023-2025 | Edarbi, Edarbi |
| Itamar Medical INC | $35.57 | 2023 | Watchpatone |
| Lilly USA, LLC | $35.26 | 2025 | Zepbound |
| Tactile Systems Technology INC | $30.23 | 2022 | |
| Althera Pharmaceuticals LLC | $26.03 | 2021 | |
| Irhythm Technologies, INC. | $24.77 | 2023 | Zio Xt Patch |
| Kestra Medical Technology Services, INC. | $20.63 | 2025 | Assure Wcd |
| Heartflow, INC. | $19.85 | 2025 | |
| Bardy Diagnostics, INC. | $17.92 | 2019 | |
| Lundbeck LLC | $16.36 | 2019 | |
| Strongbridge US INC. | $16.30 | 2020 | |
| Glaxosmithkline, LLC. | $14.36 | 2025 | Shingrix, Arexvy |
| G Medical Diagnostic Services, INC. | $13.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norman Risinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.